Geisinger Medical Laboratories Test Catalog

Order Display Name: Geisinger Epic Procedure Code Or ID CPT Code:  

BARTONELLA HENSELAE ANTIBODY (IgG) WITH REFLEX TO TITER

Geisinger Epic Procedure Code: LAB1017             Geisinger Epic ID: 51993
       

SPECIMEN COLLECTION
Specimen type:
Serum
Preferred collection container:
Alternate Collection Container:
6 mL red-top (plain, non-serum separator) tube
Specimen required:
1 mL serum; minimum 0.2 mL

SPECIMEN PROCESSING
Transport temperature:
Room temperature.
Specimen stability:
Room temperature: 7 days. Refrigerated: 14 days. Frozen: 30 days.
Rejection criteria:
Gross hemolysis; grossly lipemic; grossly icteric.

TEST DETAILS
Additional information:
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
CPT code(s):
86611
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.  The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.
Test includes:
If B. henselae (IgG) Screen is positive, then B. henselae (IgG) Titer will be performed at an additional charge (CPT code(s): 86611).
Methodology:
Immunoassay
Synonyms:
Quest test code 94761, Cat Scratch Fever, Bacillary Angiomatosis, Bart IgG
Clinical significance:
Bartonella henselae IgG results may aid in the diagnosis of recent or current B. henselae infection. Recent infection is indicated by seroconversion or increasing IgG titers when comparing results for acute and convalescent specimens tested on the same assay run.

Performing Locations

Quest Diagnostics

Technical Lead: Michael Weaver    
Frequency: Set up: Mon-Sat; Report available: 1-3 days    
Performed STAT? No
Locations  |    Search  |    Site Map |   Contact Us
©2000-2023 Geisinger Health System.   All rights reserved.